ライフサイエンスコーパス: associated virus

1 overexpressed by use of a cardiotropic adeno-associated virus.

2 RISPR/Cas9 gene editing machinery with adeno-associated virus.

3 ine heart was performed by means of an adeno-associated virus.

4 ceous nanocontainers and genome-packed adeno-associated viruses.

5 splantation of PCs pretransfected with adeno-associated virus 1-vascular endothelial growth factor-A1

6 r either virus to replicate.IMPORTANCE Adeno-associated virus 2 (AAV2) differs from most other viruse

7 On the other hand, adeno-associated virus 2 (AAV2) is a helper-dependent dependop

8 Suppression of Sema3e using adeno-associated virus 2 carrying short hairpin RNA targeting

9 cation, we constructed two recombinant adeno-associated-virus 2 (rAAV2) vectors encoding CIP fused wi

10 For HBV, HPV16, HPV18 and adeno-associated virus-2 (AAV2), viral integration was associa

11 Grapevine leafroll-associated virus 3 (GLRaV-3) is one of the most importan

12 AMT-060 combines an adeno-associated virus-5 (AAV5) vector with a liver-specific p

13 We have used Cas9 and adeno-associated virus 6 to correct the DeltaF508 mutation in

14 , were given injections of recombinant adeno-associated virus 8 vector that expressed the primary miR

15 fl) Shc mice on FFD were injected with adeno-associated virus 8-thyroxine-binding globulin-Cre-recomb

16 Adeno-associated virus 8-vascular endothelial growth factor C

17 n primate model of HIV infection, with adeno-associated virus 9 (AAV9)-CRISPR/Cas9 gene editing const

18 e symporter) to noninvasively quantify adeno-associated virus 9 (AAV9)-mediated gene expression in a

19 Similarly, adeno-associated virus 9 (AAV9)-mediated restoration of Erk5 e

20 ere, we demonstrate that a recombinant adeno-associated virus 9 (rAAV9) is highly effective for trans

21 Adeno-associated virus 9 -mediated cardiac overexpression of c

22 e were injected with M7.8L packaged in adeno-associated virus 9 at 3 days of age and 60 days of age.

23 In the present study, we delivered adeno-associated virus 9 carrying green fluorescent protein-CI

24 e performed intramuscular injection of adeno-associated virus 9 carrying the TIPE2 gene in mdx mice.

25 and treated with a sCAR-Fc expressing adeno-associated virus 9 vector 1, 3, and 7 days after CVB3 in

26 ively in cardiomyocytes by using AAV9 (adeno-associated virus 9) to deliver multiplexed single guide

27 Moreover, adeno-associated virus 9- RHEB restored cardiac growth to ATF6

28 levels in a mouse model of I/R, as did adeno-associated virus 9-mediated ATF6 overexpression.

29 Adeno-associated virus 9-mediated Cdk5 inhibitory peptide reve

30 scending coronary artery ligation, and adeno-associated virus 9-mediated in vivo overexpression in mi

31 An adeno-associated virus 9-mediated, cardiomyocyte-specific over

32 iac-specific Lrg1 delivery mediated by adeno-associated virus 9.

33 so increased in CPVT mice, and further adeno-associated virus-9-induced overexpression of SN attenuat

34 2 [ryanodine receptor 2]-R2474S) using adeno-associated virus-9-induced overexpression.

35 ptic damage in vivo, we have generated adeno-associated viruses AAV-Tat and AAV-Exo-Tat viruses.

36 We applied STN-DBS in an adeno-associated virus (AAV) 1/2-driven human mutated A53T alp

37 Here we report a rationally designed adeno-associated virus (AAV) 6 capsid that demonstrates effici

38 in 1-month old mdx:utr (-/-) mice via adeno-associated virus (AAV) 9-mediated RNA interference.

39 Using an adeno-associated virus (AAV) approach, coupled with genome edi

40 ACV CRISPR antivirals was tested using adeno-associated virus (AAV) as a packaging vector for both Sa

41 As an alternative, we developed an adeno-associated virus (AAV) based "Provector" whose cellular

42 Adeno-associated virus (AAV) capsid modification enables the g

43 Adeno-associated virus (AAV) capsids can deliver transformativ

44 We recently developed adeno-associated virus (AAV) capsids to facilitate efficient a

45 6 wks were injected unilaterally with adeno-associated virus (AAV) containing either NT3 or GFP gene

46 delivery with naturally recombinogenic adeno-associated virus (AAV) donor vectors enables site-specif

47 tasis in AMD, we delivered recombinant adeno-associated virus (AAV) encoding Abeta42 and Abeta40 pept

48 Adeno-associated virus (AAV) exhibits anterograde transneurona

49 lpha-synuclein (alpha-syn) fibrils and adeno-associated virus (AAV) expressing human wild-type alpha-

50 ceived nodose ganglia injections of an adeno-associated virus (AAV) expressing short hairpin RNAs tar

51 nvolvement in conflict, we injected an adeno-associated virus (AAV) expressing the genetically encode

52 ffective long-term therapy for NIU, an adeno-associated virus (AAV) gene therapy approach was used to

53 e therapy for corneal vascularization, adeno-associated virus (AAV) gene therapy, exploiting a natura

54 d via intrathecal administration of an adeno-associated virus (AAV) gene transfer vector significantl

55 Adeno-associated virus (AAV) has been successfully used to del

56 9 systems that can be packaged into an adeno-associated virus (AAV) hold great promise for gene thera

57 owever, in vivo delivery of mAgrin via adeno-associated virus (AAV) into FKRP mutant mice was unable

58 Adeno-associated virus (AAV) is a leading vector for virus-bas

59 Adeno-associated virus (AAV) is a promising gene therapy vecto

60 Adeno-associated virus (AAV) is a promising vector for gene th

61 Adeno-associated virus (AAV) is a replication-deficient parvov

62 Adeno-associated virus (AAV) is frequently used to manipulate

63 The adeno-associated virus (AAV) non-structural Rep proteins catal

64 protein (AAP) is a recently discovered adeno-associated virus (AAV) protein that promotes capsid asse

65 s system, we systemically delivered an adeno-associated virus (AAV) serotype 9 carrying the human GBA

66 determine the efficacy of intrathymic adeno-associated virus (AAV) serotypes to transduce thymocyte

67 The adeno-associated virus (AAV) serves as a broadly used vector s

68 ent of SDS-PAGE for purity analysis of adeno-associated virus (AAV) therapeutic products of different

69 in adult animals successfully delivers adeno-associated virus (AAV) throughout the cervical, thoracic

70 ously reported compassionate use of an adeno-associated virus (AAV) vector containing the human AADC

71 The adeno-associated virus (AAV) vector effectively transduced in

72 ateral alBST-targeted injections of an adeno-associated virus (AAV) vector expressing short hairpin R

73 Conventional methods to discern adeno-associated virus (AAV) vector transduction patterns are

74 tered a single intravenous dose of the adeno-associated virus (AAV) vector, AAV-BR1-CAG-NEMO, deliver

75 ntracerebroventricular injection of an adeno-associated virus (AAV) vector-based system encoding an a

76 Adeno-associated virus (AAV) vector-mediated gene delivery was

77 itical pre-clinical model for studying adeno-associated virus (AAV) vector-mediated gene therapies.

78 Neutralizing antibodies to adeno-associated virus (AAV) vectors are highly prevalent in h

79 Adeno-associated virus (AAV) vectors are preeminent in emergin

80 Adeno-associated virus (AAV) vectors are the leading platform

81 dentified Anc80L65 from a set of other adeno-associated virus (AAV) vectors as a potent vector for th

82 ntramuscular or systemic injections of adeno-associated virus (AAV) vectors encoding nuclease-dead Ca

83 Herein, we review the use of adeno-associated virus (AAV) vectors for delivery of HIV bNAbs

84 We investigated adeno-associated virus (AAV) vectors for gene delivery to the

85 Gene therapy with adeno-associated virus (AAV) vectors has demonstrated appropri

86 these issues, and such approaches with adeno-associated virus (AAV) vectors have been shown to be saf

87 Immune responses in gene therapy with adeno-associated virus (AAV) vectors have been the object of a

88 Adeno-associated virus (AAV) vectors have been used successful

89 Adeno-associated virus (AAV) vectors have made great progress

90 Adeno-associated virus (AAV) vectors have shown promising resu

91 HIV monoclonal antibodies (mAbs) using adeno-associated virus (AAV) vectors holds promise for the pre

92 HiUGE employs adeno-associated virus (AAV) vectors of autonomous insertional

93 ics directly into the human body using adeno-associated virus (AAV) vectors.

94 rized utrophin (uUtro), deliverable by adeno-associated virus (AAV) vectors.

95 We combined the adeno-associated virus (AAV) with the Cre-loxP site-specific r

96 e are systematically investigated with adeno-associated virus (AAV), an anterograde viral tracer.

97 present two methods for radiolabeling adeno-associated virus (AAV), one of the most commonly used vi

98 ilar efficacy by gene augmentation via adeno-associated virus (AAV), providing a proof-of-concept for

99 )-independent CRISPR-Cpf1 systems with adeno-associated virus (AAV), we were able to build a stable C

100 Adeno-associated virus (AAV)-based gene therapies can restore

101 Adeno-associated virus (AAV)-based gene therapy is a promising

102 G proliferation, along with reports of adeno-associated virus (AAV)-based MG reprogramming and functi

103 Adeno-associated virus (AAV)-Cre-mediated Vgf ablation in flox

104 a well-established mouse model, using adeno-associated virus (AAV)-delivered meganucleases, as a pot

105 ibozymes enabled in vivo regulation of adeno-associated virus (AAV)-delivered transgenes, allowing do

106 A new adeno-associated virus (AAV)-driven somatic genome-editing mod

107 We found that delivery of Adeno-associated virus (AAV)-expressing miR760 in the cerebell

108 itis B virus (HBV)-transgenic and adenovirus-associated virus (AAV)-HBV mouse models.

109 cy on atherosclerosis using a model of adeno-associated virus (AAV)-induced hypercholesterolemia.

110 an inflammatory disease model and used adeno-associated virus (AAV)-mediated Ac45 RNA interference kn

111 r HIV is a crucial public health need; adeno-associated virus (AAV)-mediated antibody gene delivery c

112 Here we report that a system of adeno-associated virus (AAV)-mediated clustered regularly inte

113 ort a genome editing approach in which adeno-associated virus (AAV)-mediated CRISPR/Cas9 delivery to

114 f a mouse model of SARS-CoV-2 based on adeno-associated virus (AAV)-mediated expression of hACE2.

115 We found that recombinant adeno-associated virus (AAV)-mediated expression of IL-10, alo

116 on of recombinant sTREM2 protein or by adeno-associated virus (AAV)-mediated expression.

117 rimary adult rat ventricular myocytes, adeno-associated virus (AAV)-mediated gene delivery in mice, a

118 ed mice with elevated expression using adeno-associated virus (AAV)-mediated gene delivery.

119 We use adeno-associated virus (AAV)-mediated gene editing to knock in

120 Adeno Associated Virus (AAV)-mediated gene expression in the b

121 Adeno-associated virus (AAV)-mediated gene therapy is currentl

122 Adeno-associated virus (AAV)-mediated gene therapy is under in

123 ere, we describe the development of an adeno-associated virus (AAV)-mediated gene therapy to treat th

124 address this challenge, we first used adeno-associated virus (AAV)-mediated gene transfer to perform

125 Adeno-associated virus (AAV)-mediated SaCas9-KKH delivery prev

126 le guide RNA cassette are nested in an adeno-associated virus (AAV).

127 icient delivery of donor template with adeno-associated virus (AAV).

128 s derived from another parvovirus, the adeno-associated virus (AAV).

129 ice that receive systemic injection of adeno-associated virus (AAV)2/1-carrying truncated gRNAs targe

130 144F) MNs, and intrathecal delivery of adeno-associated virus (AAV)9-mir-17~92 improves motor deficit

131 To address this, we developed a novel adeno-associated virus (AAV-GLP-1R) that utilizes short hairpi

132 Adeno-associated viruses (AAV) are composed of nonenveloped, i

133 Adeno-associated viruses (AAV) are helper-dependent parvovirus

134 ed by large size (limiting delivery by adeno-associated virus [AAV] vectors), off-target editing, or

135 CLC by delivering an adenovirus (or an adeno-associated virus [AAV]) that expresses Cre recombinase a

136 )/dy(2j) mouse model of MDC1A using an adeno-associated virus (AAV9) carrying a catalytically inactiv

137 was delivered to the brains of mice by adeno-associated virus (AAV9) via stereotactic injection.

138 (L-G6pc(-/-) ) mice were treated with adeno-associated viruses (AAVs) 2 or 8 directed against short

139 Adeno-associated viruses (AAVs) are commonly used for in vivo

140 Adeno-associated viruses (AAVs) are dependoparvoviruses that h

141 Adeno-associated viruses (AAVs) are frequently used for gene d

142 Among viral delivery systems, adeno-associated viruses (AAVs) are relatively safe and demons

143 Adeno-associated viruses (AAVs) are typically single-stranded

144 CRISPR-associated protein 9 (Cas9) and adeno-associated viruses (AAVs) evades adaptive immune respons

145 Adeno-associated viruses (AAVs) from clade E are often used as

146 ined cell types, recombinase-dependent adeno-associated viruses (AAVs) have become the tool of choice

147 nt AAV genome transcription.IMPORTANCE Adeno-associated viruses (AAVs) have proven to be effective ge

148 nd tight junction integrity.IMPORTANCE Adeno-associated viruses (AAVs) have recently emerged at the f

149 Delivery via adeno-associated viruses (AAVs) is limited by AAV packaging ca

150 neutralizing antibodies (NAbs) against adeno-associated viruses (AAVs) pose a major, unresolved chall

151 here by stamping cultured neurons with adeno-associated viruses (AAVs), is completed in a few minutes

152 showed 1.3- to 1.7-fold-lower growth of cell-associated virus and 3- to 6.2-fold-lower growth of cell

153 5 Snord115 genes were packaged into an adeno-associated virus and administered to a mouse model of AS

154 s versus D2-MSNs using a Cre-inducible adeno-associated virus and Cre lines during cocaine conditione

155 specific molecular interaction between adeno-associated virus and its host cell, which can be rapidly

156 amples showed similarity to Anthurium mosaic-associated virus and Persea americana chrysovirus, putat

157 ceptor 2 [sTGFbetaR2]) delivered using adeno-associated viruses and explored their ability to mitigat

158 of these two major diseases as well as their associated viruses and whitefly vector.

159 Using an adeno-associated virus approach, we validate that miR-19a/19b

160 s a long-known human pathogen, whereas adeno-associated viruses are nonpathogenic.

161 animal host, endosymbiotic dinoflagellates, associated viruses, bacteria, and other microeukaryotes.

162 Systemic injection of adeno-associated virus-BAG3(Ile81) (n=9), but not BAG3(Met81)

163 tment of a mouse model of OPMD with an adeno-associated virus-based gene therapy combining complete k

164 Adeno-associated virus-based transduction of Dnase1l3 into Dna

165 Moreover, intra-articular injection of adeno-associated virus carrying HPIP-specific short hairpin RN

166 y, overexpression of VZVsncRNA13 using adeno-associated virus consistently increased VZV spread and p

167 We present 15 adeno-associated virus constructs and 6 mouse reporter lines f

168 We have designed a double-stranded adeno-associated virus containing a rat proglucagon promoter (

169 We injected recombinant adeno-associated virus containing the CRRY coding sequence (AA

170 uantitative viral load testing of transplant-associated viruses continues to be limited by interlabor

171 sequencing results confirmed that our adeno-associated virus-CRISPR/Cas9 strategy was very efficient

172 single-dose systemic administration of adeno-associated virus-delivered CRISPR-Cas9 components suppre

173 of the gyrencephalic brain by systemic adeno-associated virus delivery in human neurological diseases

174 Intratumoral adeno-associated virus delivery of CRISPRa libraries elicited

175 s and two models of type 2 diabetes by adeno-associated virus delivery of renin (ReninAAV).

176 worked with remarkable speed to identify the associated virus, determine its relationship to animal v

177 Here, we show that adeno-associated virus-driven expression of progranulin in the

178 with a single intrathecal infusion of adeno-associated virus encoding a microRNA targeting SOD1.

179 BALB/c mice treated with adeno-associated virus encoding the BL6 BAG3 variant (Ile81; n

180 dynamic injection or transduction with adeno-associated virus encoding the HBV genome (AAV-HBV).

181 We treated mice with either adeno-associated viruses encoding a control (green fluorescent

182 Next, the anterograde transport of an adeno-associated virus expressing DREADDs was paired with loca

183 ress-susceptible or mice injected with adeno-associated virus expressing shRNA against Cldn5 caused i

184 Local injection of adeno-associated viruses expressing sgRNA-guided CjABE inhibit

185 uopathy utilizing neonatal delivery of adeno-associated viruses expressing wild-type (WT) or mutant t

186 similar results in mice infected with adeno-associated virus-expressing small hairpin RNAs targeting

187 overproduce sclerostin as a result of adeno-associated virus expression from the liver.

188 sruption of anchoring in vivo using an adeno-associated virus gene therapy vector inhibited cardiac h

189 Additionally, adeno-associated virus has demonstrated outstanding potential

190 In particular, coral-associated viruses have received little attention, and t

191 -Fos using photoreceptor-specific AAV (adeno-associated virus)-hRK (human rhodopsin kinase)-sh_c-fos

192 We injected Cre-dependent adeno-associated virus in an Rbp4-Cre transgenic mouse line (b

193 d by orotracheal transgene delivery of adeno-associated virus in mouse models of PH.

194 s, has greatly expanded our knowledge of gut-associated viruses in devils and provides important base

195 to estimate the fraction of true infectious associated viruses in viral tagging experiments.

196 orter genes into the safe-harbor locus adeno-associated virus integration site 1 in human embryonic s

197 dition, introduction of 3xMyc-FXR1 via adeno-associated virus into mice leads to the redistribution o

198 ISPRa, we injected CRISPRa-recombinant adeno-associated virus into the hypothalamus, which led to rev

199 the packaging capacity of recombinant adeno-associated virus is limited while tissue-specific delive

200 Systemic delivery of dCas9/gRNA by adeno-associated virus led to reductions in pathological RNA f

201 e considered mechanical vectors of honey bee-associated viruses, making them a potential threat to po

202 rs virus function, and we suggest that tumor-associated viruses may be more likely to contain DNA mix

203 s of KLF5 function approaches and AAV (adeno-associated virus)-mediated Klf5 delivery in mice showed

204 on and that induction of NRF2 using an adeno-associated virus-mediated approach in hepatocytes in viv

205 ared axons, using projection-specific, adeno-associated virus-mediated chemogenetic neuronal silencin

206 striatal cell culture model of HD, and adeno-associated virus-mediated Elk-1 overexpression alleviate

207 we explored the effects of recombinant adeno-associated virus-mediated expression of Abeta38 and Abet

208 Furthermore, adeno-associated virus-mediated expression of CCN1 reversed th

209 letion in the NAc in adult mice, using adeno-associated virus-mediated expression of cre recombinase,

210 e intravitreally delivered recombinant adeno-associated virus-mediated expression of soluble Fms-rela

211 To assess efficacy in vivo, we used adeno-associated virus-mediated expression of the most potent

212 Conditional gene deletion and adeno-associated virus-mediated gene delivery in the mouse wer

213 the JCI, Wang et al. demonstrate that adeno-associated virus-mediated overexpression of TGF-beta1 pr

214 ls and in mice by peptide injection or adeno-associated virus-mediated overexpression.

215 Adeno-associated virus-mediated Snapin overexpression in the h

216 Adeno-associated virus-mediated targeting of RGMa to mouse DA

217 In contrast, transgenic or adeno-associated virus-mediated TNFAIP3 gene delivery in the l

218 Here we developed an adeno-associated virus-mediated, autochthonous genetic CRISPR

219 ction of an engineered virus, often an adeno-associated virus or herpes simplex virus, among many oth

220 A, compared with cells transduced with adeno-associated virus or lentivirus expressing SaCas9.

221 stereotactic hippocampal injections of adeno-associated virus particles in mutant hAPP Tg mouse brain

222 We generated multifunctional hybrid adeno-associated virus/phage (AAVP) particles to enable simult

223 Adeno-associated virus-progranulin also corrected lysosomal ab

224 The adeno-associated virus-progranulin vector only transduced neur

225 intranigral injections of recombinant adeno-associated virus pseudotype 2/5 to overexpress wildtype

226 At day 28, recombinant adeno-associated virus (rAAV) (5 x 10(12) viral particles enco

227 Infusion of a recombinant adeno-associated virus (rAAV) containing a functional Avp gene

228 recent market approvals of recombinant adeno-associated virus (rAAV) gene therapies in Europe and the

229 Recombinant adeno-associated virus (rAAV) is an attractive tool for basic

230 d release of a therapeutic recombinant adeno-associated virus (rAAV) vector overexpressing the chondr

231 he non-tumor-bearing (NT), recombinant adeno-associated virus (rAAV) vector-treated GSD-Ia mice (AAV-

232 microdystrophin genes and recombinant adeno-associated virus (rAAV) vectors is an attractive strateg

233 rapy in G6pt-/- mice using recombinant adeno-associated virus (rAAV) vectors, directed by either the

234 Recombinant adeno-associated viruses (rAAVs) are currently considered the

235 Recombinant adeno-associated viruses (rAAVs) are efficient gene delivery v

236 transducing the BSCs with recombinant adeno-associated viruses (rAAVs) that express alpha-synuclein

237 Adeno-associated virus receptor (AAVR) (also named KIAA0319L)

238 Delivery of apoptotic RASER by adeno-associated virus selectively ablated ErbB-hyperactive ca

239 Specifically, we labeled adeno-associated virus serotype 10 expressing the coding seque

240 3 types of icosahedral viral capsids: Adeno Associated Virus serotype 2 (AAV2) and Minute Virus of M

241 y performing intraspinal injections of adeno-associated virus serotype 2 (AAV2)-BDNF vector.

242 n to recent clinical translation in an adeno-associated virus serotype 2-mediated human aromatic L-am

243 Adeno-associated virus serotype 5 (AAV5) is being developed as

244 intravenous dose of a codon-optimized adeno-associated virus serotype 5 (AAV5) vector encoding a B-d

245 Finally, adeno-associated virus serotype 8 (AAV8)-mediated reexpression

246 ological doses of MIS, using either an adeno-associated virus serotype 9 (AAV9) gene therapy vector o

247 gene therapy for NPC1, we constructed adeno-associated virus serotype 9 (AAV9) vectors to deliver th

248 human leukocyte antigen (HLA)-A2.1 by adeno-associated virus serotype 9 (AAV9) vectors.

249 e modulated expression of FTO by using adeno-associated virus serotype 9 (in vivo), adenovirus (both

250 s expressed using a self-complementary adeno-associated virus serotype 9 (scAAV9) viral vector in the

251 Adeno-associated virus serotype 9 carrying cardiac-specific co

252 received a single dose of intravenous adeno-associated virus serotype 9 carrying SMN complementary D

253 In contrast, mice injected with adeno-associated virus serotype 9 encoding PDE4B (10(12) viral

254 Similarly, adeno-associated virus serotype 9 encoding PDE4B slowed contra

255 pecific overexpression of PDE4B and an adeno-associated virus serotype 9 encoding PDE4B.

256 An in vivo rescue experiment with adeno-associated virus serotype 9 TnT-MEK1-CA nearly abolished

257 /Cas9-based cardiac gene editing using adeno-associated virus serotype 9 to deliver a single short gu

258 In vivo, AAV9 (adeno-associated virus serotype 9)-mediated cardiac overexpres

259 Using intrathecal adeno-associated virus serotype 9-based delivery, the glutamat

260 lications, we found that prior in vivo Adeno-associated virus serotype 9-mediated gene delivery of GJ

261 METHODS AND Using an in vivo Adeno-associated virus serotype 9-mediated gene transfer syste

262 e employed systemic administration via adeno-associated virus serotype 9.

263 ctivation by genetic overexpression or adeno-associated virus serotype-9-based gene delivery was capa

264 eover, IRE-1 activator, Quercetin, and adeno-associated virus serotype-9-delivered XBP-1s were able t

265 ced by intraparenchymal delivery of an adeno-associated virus-short hairpin RNA construct was suffici

266 was genetically targeted using a novel adeno-associated virus shuttle vector to deliver microRNA-adap

267 r administration of miR-204-expressing adeno-associated virus significantly decelerates OA progressio

268 We found a high prevalence of known tumor-associated viruses such as Epstein-Barr virus (EBV), hep

269 in the VTA, we delivered Cre-inducible adeno-associated virus that drives the expression of fluoresce

270 ingle intravenous administration of an adeno-associated virus that encodes CRISPR (AAV-CRISPR).

271 TS-HIF-1alpha(-/-) ) by microinjecting adeno-associated virus that expressed Cre-recombinase in HIF-1

272 that of crAssphage, the most abundant human-associated virus that is found in about 50% of human gut

273 ed into NAc variants of a new designer adeno-associated virus that permits robust retrograde access t

274 a transgene or after infection with an adeno-associated virus that transferred an overlength HBV geno

275 ce, using Cre recombinase delivered by adeno-associated virus to knockout endogenous hepatic Insr acu

276 Vectors based on adeno-associated virus type 2 (AAV2) are powerful tools for ge

277 in patients with hepatitis B virus or adeno-associated virus type 2 infection might involve activati

278 nts infected with hepatitis B virus or adeno-associated virus type 2, due to integration of the virus

279 t transgenic Cre mice or injected with adeno-associated virus type 8 (AAV8) Cre and fed diets to prom

280 XCL10(-/-) mice, using the neurotropic adeno-associated virus type 8 (AAV8) vector, boosted the numbe

281 reus) and guide RNA constructs into an adeno-associated virus vector and systemically delivered them

282 K(b) D(b)) (null) ( IA(null)) mice via adeno-associated virus vector increased human CD45(+) cell eng

283 Genomic integration of the adeno-associated virus vector into Cas9 target sites caused pr

284 administration of an FGF21-expressing adeno-associated virus vector recapitulated these complication

285 Intravascular injection of certain adeno-associated virus vector serotypes can cross the blood-br

286 approach for Alzheimer's disease using adeno-associated virus vector-based knockdown of CD33 reduced

287 tor retargeting.IMPORTANCE Recombinant adeno-associated virus vectors (rAAVs), based on AAV8 and AAVr

288 Using retrograde adeno-associated virus vectors and transgenic mice expressing

289 Intrahippocampal injections of adeno-associated virus vectors containing the astrocyte-specif

290 elements in the context of recombinant adeno-associated virus vectors has enabled cell-type-restricte

291 g in a common mouse model of AD, using adeno-associated virus vectors normalized glutamate signaling

292 patients, and gene augmentation using adeno-associated virus vectors robustly sustained the rescue o

293 blies, similar to the best recombinant adeno-associated virus vectors.

294 type mice via stereotaxic injection of adeno-associated virus, we found that adult cerebellar neurons

295 e if any of six commonly occurring honey bee-associated viruses were present in ants collected from w

296 bited incomplete neutralization against cell-associated virus with T/F Envs, which was not observed w

297 simultaneously differentiates all 169 human-associated viruses with at least 10 published genome seq

298 understand the long-term impacts of outbreak-associated viruses within medical systems using traditio

299 ors can package larger transgenes than adeno-associated viruses, yet lentiviral vectors remain largel

300 specific overexpression of human ZIP8 (adeno-associated virus-ZIP8 [AAV-ZIP8]) resulted in increased